Hjernegym - Effects of Exergaming in Psychosis: a Clinical Intervention Study
Sykehuset i Vestfold HF
48 participants
Mar 29, 2023
INTERVENTIONAL
Conditions
Summary
The goal of this clinical intervention study is to investigate the effects of exergaming on cognition and other clinical symptoms in outpatient individuals with schizophrenia. The main questions it aims to answer are: Will an exergaming intervention contribute to improved cognition and reduced clinical symptoms, as well as enhanced physical health/self-efficacy/quality of life, in individuals with schizophrenia? Will the gaming component strengthen motivation for a physically more intensive component, so that attendance will be at least as high as in comparable exercise studies despite the current study being implemented in a resource-limited, regular clinical outpatient setting? Participants will be asked to engage in two 45 minutes exergaming sessions with a designated personal trainer for 12 weeks. Results pre- and post intervention will be compared, and comparisons will also be made with a former randomized controlled trial conducted at the same site, in which the currently combined activities were investigated separately (high-intensity interval training and low-intensity video gaming), both yielding positive but different effects.
Eligibility
Inclusion Criteria3
- Having consent capability
- Understanding and speaking Scandinavian language
- Fulfilling the International Classification of Diseases Tenth Revision (ICD 10) criteria for schizophrenia spectrum disorder (schizophrenia, schizoaffective disorder and schizophreniform disorder)
Exclusion Criteria11
- Diagnosis of intellectual disability
- Diagnosis of neurological disorder
- History of severe head trauma
- Pregnancy
- Chest pain during exercise
- Unstable angina pectoris
- Malignant hypertension
- Uncontrollable arrhythmia
- Recent myocardial infarction
- Acute infection with lymphadenopathy
- Other specified medical condition incompatible with participation
Interventions
Please see Arms description.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05858255